chartexchange

RPG Life Sciences eyes another acquisition with ₹500 crore capital pool

Business Standard | Nov 1, 2026 7:50 AM EST

The drugmaker plans to deploy ₹500 crore for another acquisition within 12 months as it targets 25 per cent annual growth in its API business over the next five years

Read original article